Clinical Scorecard: PFAS Linked to Lipid Changes in Children
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: PFAS Linked to Lipid Changes in Children
Key Mechanisms
Higher perfluoroundecanoic acid concentrations were associated with higher total and LDL cholesterol across the cohort. Associations varied by sex and pubertal stage; the study could not determine cause and effect.
Target Population
Population described in the source article.
Care Setting
Care setting described in the source article.
Key Highlights
Six PFAS were detected in 93% to 100% of participants’ serum samples.
Across the cohort, higher perfluoroundecanoic acid concentrations were associated with higher total and LDL cholesterol.
Among pre-menarcheal girls, perfluorohexane sulfonate and the combined PFAS mixture were associated with higher total and LDL cholesterol.
Among boys in early puberty, perfluorononanoic acid and perfluorodecanoic acid were associated with higher triglycerides; among postpubertal boys, perfluorooctane sulfonate was associated with lower triglycerides.
PFAS and metabolic markers were measured at the same time, so the researchers could not determine cause and effect. The study did not examine whether marker differences persist into adulthood.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
451 children from the PELAGIE mother-child cohort in Brittany, France; median age 12.8 years, and 86% had a BMI within the normal range.
No treatment or prescribing intervention was studied. The authors called for longitudinal studies with repeated exposure and metabolic measurements.
